HORSHAM, Pa.--(BUSINESS WIRE)--NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today NextGen® Ambulatory EHR version 5.8.1 is compliant with the ONC 2014 Edition criteria for certification measures 170.314(f)(5), Cancer Case Information, and 170.314(f)(6), Transmission to Cancer Registries, both in the Ambulatory setting, in accordance with the applicable Eligible certification criteria adopted by the Secretary of Health and Human Services (HHS). The ONC 2014 Edition criteria support both Stage 1 and 2 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA). This new capability will allow NextGen Healthcare clients to attest to in Meaningful Use Stage 2 Menu Objective 5 (Identify and report cancer cases).
The Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs provide financial incentives for the "meaningful use" of certified EHR technology to improve patient care. To receive an EHR incentive payment, providers have to show that they are "meaningfully using" their EHRs by meeting thresholds for a number of objectives. One optional menu set measure for Stage 2 is the reporting of cancer cases; successful ongoing submission of cancer case information from Certified Electronic Health Record Technology (CEHRT) to a public health central cancer registry for the entire EHR reporting period.
Cancer reporting from all healthcare providers (e.g., hospital, laboratory and ambulatory) for public health surveillance is mandated at the state, territory and province level. Additionally, population-based public health central cancer registries (CCRs) across the U.S. and most of Canada are required to collect complete and timely cancer diagnostic, treatment, and outcome data from hospitals, physician offices, treatment centers, clinics, laboratories, and other sources. Data collected by local cancer registries enable public health professionals to understand and address the cancer burden more effectively.
Leveraging Certified EHR technology can improve the process by identifying reportable cancer cases and treatments to the provider and facilitating electronic reporting either automatically or upon provider verification. Public health central cancer registry data are used for surveillance, development of comprehensive cancer control programs, and healthcare planning and interventions.
“NextGen Healthcare’s success in the development, testing and certification for this objective is an expression of our commitment to the use of healthcare IT to improve overall public health,” said Dr. Sarah Corley, chief medical officer for NextGen Healthcare. “Registries serve a crucial role in strategies to increase early detection of diseases and implement evidence-based improvements in prevention and treatment. While most states and jurisdictions do not presently have cancer registries in production, NextGen Healthcare is proud to be on the leading edge of healthcare and EHR industry stakeholders driving the adoption of interoperability standards needed to support new registries.”
About NextGen Healthcare
NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, connectivity and financial solutions, including revenue cycle management services for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen, Facebook at http://www.facebook.com/NextGenHealthcare or LinkedIn at http://www.linkedin.com/company/nextgen-healthcare-information-systems.
|
Certain statements in this news release are forward-looking statements within the meaning of the federal securities laws, including but not limited to those statements made by Dr. Sarah Corley related to the Company’s future products and offerings, and developments and trends in the healthcare industry. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company’s expectations and projections. Factors that could cause the anticipated results to differ from those described in the forward-looking statements include the possibility that the Company’s products will not achieve or sustain market acceptance; the impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in our software; changing economic, political or regulatory influences in the healthcare industry; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; and general economic conditions. Additional risks and uncertainties are set forth in the Company’s public filings with the U.S. Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. The Company expressly disclaims any intent or obligation to update these forward-looking statements except as required by law. |
|
© 2014 Quality Systems, Inc., Irvine, CA 92612 |
|
® marks owned by Quality Systems, Inc. |
|
All other non-QSI Marks are the property of their respective owners |
